Challenges Faced by Patients while Undertaking Treatment for Tuberculosis
DOI:
https://doi.org/10.47611/jsrhs.v11i2.2534Keywords:
Tuberculosis, DOTS centre, New Delhi, Challenges, Patients, Cost, Isolation, Side-effects, Inconvenience, Transport, IncomeAbstract
Despite the immunisation of 92% of the Indian population against tuberculosis with the bacille Calmette-Guerin vaccine (Statistica, 2019), India recorded 79,000 deaths due to this bacterial infection (The Times of India, 2020). Professionals in the field have tried to find the reason behind the high mortality and high infection rate in the country with the aim of eliminating tuberculosis in India by 2025 as part of the TB National Strategic Plan. A significant reason identified for this phenomenon is non-adherence to treatment due to challenges faced by the patients while undertaking treatment. The aim of the present research study is to identify the challenges faced by Indian tuberculosis patients visiting a dispensary in South Delhi undertaking treatment for tuberculosis and evaluating their relative importance in influencing their treatment experience through a mixed-method approach. The study was carried out by conducting a survey via phone with 35 Tuberculosis patients. Financial difficulties/loss of job/ school was found to have the highest mean rating which mirrors the trend in other developing countries such as Bangladesh. The study has implications for the government at different levels and private hospitals can be convinced that providing free-of-cost treatment is not enough and more budget should be allocated to tuberculosis treatment to ensure that patients receive a wholesome diet during and post-treatment. These changes combined would be a great step to improving public health crises such as the transmission of infectious diseases in developing countries like India.
Downloads
References or Bibliography
Aibana, O., Dauria, E., Kiriazova, T., Makarenko, O., Bachmaha, M., Rybak, N., Flanigan, T. P., Petrenko, V., Becker, A. E., & Murray, M. B. (2020). Patients' perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study. BMJ open, 10(1), e032027.
American Lung Association. (2020, October 24). Tuberculosis.
https://www.lung.org/lung-health-diseases/lung-disease-lookup/tuberculosis/learn-about-tuberculosis
Bagchi, S., Ambe, G., & Sathiakumar, N. (2010). Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. International journal of preventive medicine, 1(4), 223–232.
Gebreweld, F. H., Kifle, M. M., Gebremicheal, F. E., Simel, L. L., Gezae, M. M., Ghebreyesus, S. S., Mengsteab, Y. T., & Wahd, N. G. (2018). Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. Journal of health, population, and nutrition, 37(1), 1.
Gebreweld, F. H., Kifle, M. M., Gebremicheal, F. E., Simel, L. L., Gezae, M. M., Ghebreyesus, S. S., Mengsteab, Y. T., & Wahd, N. G. (2018). Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. Journal of health, population, and nutrition, 37(1), 1.
Harvard Health Publishing. (2019, January 2). Tuberculosis.
https://www.health.harvard.edu/a_to_z/tuberculosis-a-to-z
Kulkarni, P., Akarte, S., Mankeshwar, R., Bhawalkar, J., Banerjee, A., & Kulkarni, A. (2013). Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment. Annals of medical and health sciences research, 3(1), 67–74.
Mayo Clinic. n.d. Tuberculosis.
https://www.mayoclinic.org/diseases-conditions/tuberculosis/symptoms-causes/syc-20351250
RAI, Neeraj et al. An assessment of treatment compliance among patients on DOTS under revised national tuberculosis control programme in district Rewa, Madhya Pradesh, India. International Journal Of Community Medicine And Public Health, [S.l.], v. 2, n. 4, p. 373-379, feb. 2017.
Rai, N., Kushwah, S., Singh, S., & Dubey, D. (2017). An assessment of treatment compliance among patients on DOTS under revised national tuberculosis control programme in district Rewa, Madhya Pradesh, India. International Journal Of Community Medicine And Public Health, 2(4), 373-379.
Rodriguez,D.(2010, December 16). Death From a Preventable Disease:Tuberculosis. Everyday Health. https://www.everydayhealth.com/tuberculosis/death-from-a-preventable-disease.aspx
Sandhu G. K. (2011). Tuberculosis: current situation, challenges and overview of its control programs in India. Journal of global infectious diseases, 3(2), 143–150.
Subbaraman,R. Thomas, B. Kumar,J. Thiruvengadam,K. Khandewale,A. Kokila, S. Lubeck-Schricker,M. Kumar,M. Gaurkhede,G. Shashikant Walgude,A. Hephzibah Mercy,J. Dattatraya Kumbhar,J. Eliasziw,M. Mayer & K. Haberer, J. (2021,January 15). Understanding non-adherence to tuberculosis medications in India using urine drug metabolite testing: a cohort study. medRxiv.
World Health Organization. (2021, October 14). Tuberculosis.
https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Published
How to Cite
Issue
Section
Copyright (c) 2022 Suveera Batra
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.